S
Sam S. Chang
Researcher at Vanderbilt University Medical Center
Publications - 435
Citations - 15007
Sam S. Chang is an academic researcher from Vanderbilt University Medical Center. The author has contributed to research in topics: Bladder cancer & Cystectomy. The author has an hindex of 63, co-authored 399 publications receiving 13156 citations. Previous affiliations of Sam S. Chang include Vanderbilt University.
Papers
More filters
Journal ArticleDOI
Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline.
Sam S. Chang,Bernard H. Bochner,Roger Chou,Robert Dreicer,Ashish M. Kamat,Seth P. Lerner,Yair Lotan,Joshua J. Meeks,Jeff M. Michalski,Todd M. Morgan,Diane Zipursky Quale,Jonathan E. Rosenberg,Anthony L. Zietman,Jeffrey M. Holzbeierlein +13 more
TL;DR: This guideline attempts to improve a clinician's ability to evaluate and treat each patient, but higher quality evidence in future trials will be essential to improve level of care for these patients.
Journal ArticleDOI
Kidney Cancer, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology
Robert J. Motzer,Eric Jonasch,Neeraj Agarwal,Sam B. Bhayani,William P Bro,Sam S. Chang,Toni K. Choueiri,Brian A. Costello,Ithaar Derweesh,Mayer Fishman,Thomas H. Gallagher,John L. Gore,Steven L. Hancock,Michael R. Harrison,Won Kim,Christos Kyriakopoulos,Chad A. LaGrange,Elaine T. Lam,Clayton Lau,M. Dror Michaelson,Thomas Olencki,Phillip M. Pierorazio,Elizabeth R. Plimack,Bruce G. Redman,Brian Shuch,Brad Somer,Guru Sonpavde,Jeffrey A. Sosman,Mary A. Dwyer,Rashmi Kumar +29 more
TL;DR: The NCCN Guidelines for Kidney Cancer provide multidisciplinary recommendations for the clinical management of patients with clear cell and non-clear cell renal carcinoma.
Journal ArticleDOI
Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial
Dipen J. Parekh,Isildinha M. Reis,Erik P. Castle,Mark L. Gonzalgo,Michael Woods,Robert S. Svatek,Alon Z. Weizer,Badrinath R. Konety,Mathew Tollefson,Tracey L. Krupski,Norm D. Smith,Ahmad Shabsigh,Daniel A. Barocas,Marcus L. Quek,Atreya Dash,Adam S. Kibel,Adam S. Kibel,Lynn Shemanski,Raj S. Pruthi,Jeffrey S. Montgomery,Christopher J. Weight,David Sharp,Sam S. Chang,Michael S. Cookson,Gopal N. Gupta,Alex Gorbonos,Edward Uchio,Eila C. Skinner,Vivek Venkatramani,Nachiketh Soodana-Prakash,Kerri Kendrick,Joseph A. Smith,Ian M. Thompson +32 more
TL;DR: In patients with bladder cancer, robotic Cystectomy was non-inferior to open cystectomy for 2-year progression-free survival and increased adoption of robotic surgery in clinical practice should lead to future randomised trials to assess the true value of this surgical approach in patients with other cancer types.
Journal ArticleDOI
Postoperative nomogram predicting risk of recurrence after radical cystectomy for bladder cancer.
Bernard H. Bochner,Guido Dalbagni,Michael W. Kattan,Paul A. Fearn,Kinjal C. Vora,Song Seo Hee,Lauren Zoref,Hassan Abol-Enein,Mohamed A. Ghoneim,Peter T. Scardino,Dean F. Bajorin,Donald G. Skinner,John P. Stein,Gus Miranda,Jürgen E. Gschwend,Bjoern G. Volkmer,Richard E. Hautmann,Sam S. Chang,Michael S. Cookson,Joseph A. Smith,George Thalman,Urs E. Studer,Cheryl T. Lee,James E. Montie,Darien Wood,Juan Palou,Yyes Fradet,Louis Lacombe,Pierre Simard,Mark P. Schoenberg,Seth P. Lerner,Amnon Vazina,Pierfrancesco Bassi,Masaru Murai,Eiji Kikuchi +34 more
TL;DR: An international bladder cancer nomogram predicting recurrence risk after radical cystectomy for bladder cancer outperformed prognostic models that use standard pathologic subgroupings and should improve the ability to provide accurate risk assessments to patients after the surgical management of bladder cancer.
Journal ArticleDOI
Analysis of Early Complications After Radical Cystectomy: Results of a Collaborative Care Pathway
TL;DR: The acceptable rate of early morbidity in this series in a 5-year period validates its use in patients undergoing radical cystectomy.